We Can Medicines Co., Ltd. (TPEX:6929)

Market Cap	1.35B -32.3%
Revenue (ttm)	3.22B -1.5%
Net Income	-73.21M
EPS	-1.63
Shares Out	45.07M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Average Volume	7,225
Open	30.00
Previous Close	30.50
Day's Range	30.00 - 30.00
52-Week Range	26.15 - 36.60
Beta	-0.38
RSI	44.25
Earnings Date	May 8, 2026

About We Can Medicines

We Can Medicines Co., Ltd. operates a chain of drug stores in Taiwan. The company offers medicine, health food, maternal and baby product, beauty care products, and medical equipment. It sells its products through retail stores and online under the VITALPLUS and Sapporo brands. The company was formerly known as Shenglin Pharmaceutical Co., Ltd. The company was founded in 1972 and is headquartered in Taichung, Taiwan. We Can Medicines Co., Ltd. operates as a subsidiary of Yousheng Medical Technology Co., Ltd.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1972
• Employees: 1,005
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6929

Financial Performance

In 2025, We Can Medicines's revenue was 3.22 billion, a decrease of -1.45% compared to the previous year's 3.27 billion. Losses were -73.21 million, 55.2% more than in 2024.